Blood and tissue samples as ‘human subjects’ (360G-Wellcome-201643_Z_16_Z)

£39,897

This project examines transformations in the definition of the human research subject in biomedical research. Historically, ethical concerns arose around the reasonably well-defined category of the human subject, with ensuing allowances to address animal welfare and human embryos. However, such divisions are now undergoing substantial revisions. On September 8 2015, the US announced an overhaul for research regulations – the expansion of the definition of ‘human subject’ to include biospecimens (i.e., blood and tissue samples). Such changes point towards the increasing importance of biospecimens in health research, along with their politicization. In addition, advisory bodies have issued guidance on the ‘humanization’ of other life forms brought about by the increasing use of human biological material in other animals (e.g. human ‘admixed embryos’ in the UK & the US moratorium announced on 23 September 2015 for animals containing human cells in early development). This project investigates such new and changing understandings of the human subject in biomedical research through a qualitative based pilot study in the US and Germany. In addition, it will lay the groundwork for a large future grant application by establishing a collaborative and international research network to address these developments from local and global perspectives.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 39897
Applicant Surname Hinterberger
Approval Committee Seed Committee, Humanities and Social Science
Award Date 2016-03-10T00:00:00+00:00
Financial Year 2015/16
Grant Programme: Title Seed Award in H&SS
Internal ID 201643/Z/16/Z
Lead Applicant Dr Amy Hinterberger
Partnership Value 39897
Planned Dates: End Date 2017-08-01T00:00:00+00:00
Planned Dates: Start Date 2016-10-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region West Midlands